New Jersey · 2026-2027 Regular Session · Bill
S 4601: Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 4601 is a bill introduced in the New Jersey Senate on September 28, 2026. According to its official title, it concerns: Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product. Primary sponsor: Joe Vitale (Democratic), Linda Greenstein (Democratic). It lists 1 additional sponsor. Most recent recorded action (October 29, 2026): Received in the Assembly, Referred to Assembly Health Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Joe Vitale | Primary sponsor | Democratic | Senate | 19 |
| Linda Greenstein | Primary sponsor | Democratic | Senate | 14 |
| Raj Mukherji | Co-sponsor | Democratic | Senate | 32 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Received in the Assembly, Referred to Assembly Health Committee
- Passed by the Senate (39-0)
- Reported from Senate Committee with Amendments, 2nd Reading
- Transferred to Senate Health, Human Services and Senior Citizens Committee
- Introduced in the Senate, Referred to Senate Commerce Committee